REQUEST A DEMO
Total
USD $0.00
Search more companies

Ruda-Pharma Patika Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: RUDA-PHARMA PATIKA Gyogyszereszeti Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Ruda-Pharma Patika Bt. is an enterprise based in Hungary. Its main office is in Rudabanya. The company operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on October 15, 1996. 3 (2024) employees currently work for Ruda-Pharma Patika Bt.. In 2023, the company reported a net sales revenue increase of 5.45%. During that time, Ruda-Pharma Patika Bt.’s total assets grew by 2.62%. In 2023, Ruda-Pharma Patika Bt.’s net profit margin decreased by 0.7%.

Headquarters
Gvadanyi utca 26.
Rudabanya; Borsod-Abauj-Zemplen; Postal Code: 3733

Contact Details: Purchase the Ruda-Pharma Patika Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Ruda-Pharma Patika Bt. report to view the information.
Outstanding Shares:
Purchase the Ruda-Pharma Patika Bt. report to view the information.
Registered Capital:
Purchase the Ruda-Pharma Patika Bt. report to view the information.
Incorporation Date:
October 15, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Ruda-Pharma Patika Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
5.45%
Total operating revenue
8.43%
Operating profit (EBIT)
4.4%
EBITDA
10.42%
Net Profit (Loss) for the Period
1.16%
Total assets
2.62%
Total equity
-35.52%
Operating Profit Margin (ROS)
-0.18%
Net Profit Margin
-0.7%
Return on Equity (ROE)
12%
Quick Ratio
-2.03%
Cash Ratio
-2.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?